Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Obes Surg ; 29(6): 1765-1772, 2019 06.
Artículo en Inglés | MEDLINE | ID: mdl-30734230

RESUMEN

INTRODUCTION: Bariatric surgery is used to treat severe obesity. We aimed to investigate the incidence of clinically significant bone mineral density (BMD) loss at 6 and 12 months after bariatric surgery. METHODS: Observational study performed in a specialized center for the treatment of obesity at the University Hospital of Reims, France. Surface BMD was measured by dual x-ray absorptiometry (DEXA). A reduction of > 0.03 g/cm2 was considered clinically significant. RESULTS: A total of 110 patients were included. A clinically significant reduction in BMD was observed in 62.1% of patients at 6 months, and in 71.6% at 12 months after surgery. No case of osteoporosis was observed. There were four cases of osteopenia and one fracture post-surgery. BMD loss was related by univariate analysis to the reduction in body mass index (BMI) (p < 0.01), weight loss (p < 0.01), fat mass (p < 0.01), and lean mass (p < 0.01). Multivariable analysis found a significant association between the reduction in BMD and the excess weight loss percentage (odds ratio 1.11, 95% confidence interval (1.05-1.18), p < 0.001). CONCLUSION: There was a clinically significant reduction in BMD at 6 months after surgery in over 60% of patients undergoing bariatric surgery. BMD loss is persistent over time and predominantly situated at the femoral level, and strongly associated with weight loss. Systematic vitamin and calcium supplementation, as well as follow-up by DEXA scan seems appropriate. Systematic DEXA scan pre- and post-surgery, and annually thereafter until weight has stabilized seems appropriate.


Asunto(s)
Cirugía Bariátrica/efectos adversos , Enfermedades Óseas Metabólicas/epidemiología , Obesidad Mórbida/cirugía , Complicaciones Posoperatorias/epidemiología , Absorciometría de Fotón , Adulto , Índice de Masa Corporal , Femenino , Francia , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Factores de Tiempo , Pérdida de Peso
3.
PLoS One ; 12(9): e0185058, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28931052

RESUMEN

OBJECTIVES: To assess the effects of bariatric surgery in patients with obesity on dyspnea and to analyze the relationships between improvement of dyspnea after bariatric surgery and changes in pulmonary function, especially Expiratory Reserve Volume (ERV) which is the lung volume abnormality most frequently associated with obesity. METHODS: Forty-five patients (5 males/40 females, mean Body Mass Index = 46.2 ± 6.8 kg/m2) were evaluated before and 6 to 12 months after bariatric surgery. Dyspnea was assessed by the modified Medical Research Council (mMRC) scale. Pulmonary function tests, arterial blood gases and six-minute walk test were performed. Laboratory parameters including C-Reactive Protein (CRP) were analyzed. RESULTS: Ninety percent of patients were dyspneic before surgery (mMRC scale ≥ 1) versus 59% after surgery (p<0.001). Mean mMRC score improved after bariatric surgery (1.5 ± 0.9 vs 0.7 ± 0.7, p<0.0001). Among patients with dyspnea before surgery (n = 38), a more marked increase in ERV after surgery was observed in patients with improvement of dyspnea compared to patients with no improvement of dyspnea (+0.17 ± 0.32 L vs +0.49 ± 0.35 L, p = 0.01). Multivariate analysis including age, variation of BMI, variation of CRP, variation of Total Lung Capacity and variation of ERV demonstraded that ERV was the only variable associated with improvement of the mMRc score after bariatric surgery (p = 0.04). CONCLUSION: Weight loss associated with bariatric surgery improves dyspnea in daily living. This improvement could be partly related to increased ERV.


Asunto(s)
Cirugía Bariátrica , Disnea/fisiopatología , Volumen de Reserva Espiratoria , Adulto , Análisis de los Gases de la Sangre , Disnea/terapia , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Pletismografía , Estudios Prospectivos , Pruebas de Función Respiratoria
4.
Pathol Res Pract ; 210(3): 189-93, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24315830

RESUMEN

Filiform polyposis (FP) is a distinctive and unusual form of benign non syndromic polyposis that is occasionally encountered in the colon of patients with inflammatory bowel disease (IBD) history. FP is characterized by one to hundreds, slender, arborizing, vermiform projections in the colon lined by normal or inflammatory colonic mucosa. Only rare cases without history or evidence of IBD have been reported. In those cases, the sigmoid colon was the most common location and none of them showed dysplasia or malignancy neither at first evaluation nor during follow-up. In this report, we present the first case of FP associated with six adenomas developed on filiform polyps and invasive adenocarcinoma in the right colon of a 54 year-old man without a past medical history of IBD.


Asunto(s)
Adenocarcinoma/patología , Pólipos Adenomatosos/patología , Neoplasias del Colon/patología , Pólipos del Colon/patología , Poliposis Intestinal/patología , Adenocarcinoma/genética , Adenocarcinoma/cirugía , Pólipos Adenomatosos/genética , Pólipos Adenomatosos/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Biopsia , Colectomía , Neoplasias del Colon/genética , Neoplasias del Colon/cirugía , Pólipos del Colon/genética , Pólipos del Colon/cirugía , Análisis Mutacional de ADN , Femenino , Humanos , Poliposis Intestinal/genética , Poliposis Intestinal/cirugía , Masculino , Inestabilidad de Microsatélites , Persona de Mediana Edad , Mutación , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas p21(ras) , Adulto Joven , Proteínas ras/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...